$MPW
MEDICAL PROPERTIES TRUST INC Stock $mpw

$mpw Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000095017024065929 Filed on May 29, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$266.6M	$271.3M
YoY Change	-20.99%	-22.53%
Cost Of Revenue	$7.663M	$4.818M
YoY Change	-68.95%	-97.35%
Gross Profit	$258.9M	$266.5M
YoY Change	-17.21%	58.49%
Gross Profit Margin	97.13%	98.22%
Selling, General & Admin	$35.33M	$33.35M
YoY Change	-0.78%	-20.07%
% of Gross Profit	13.65%	12.51%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$103.9M	$75.59M
YoY Change	-71.5%	-13.7%
% of Gross Profit	40.12%	28.36%
Operating Expenses	$137.6M	$108.9M
YoY Change	-65.61%	-13.26%
Operating Profit	$121.3M	$157.6M
YoY Change	-239.0%	270.16%
Interest Expense	$101.4M	-$98.14M
YoY Change	-208.99%	-200.49%
% of Operating Profit	83.6%	-62.28%
Other Income/Expense, Net	-$325.0M	-$89.35M
YoY Change	2991.72%	7.27%
Pretax Income	-$305.1M	-$724.4M
YoY Change	59.99%	-2080.77%
Income Tax	$14.56M	$10.95M
% Of Pretax Income
Net Earnings	-$320.6M	-$735.6M
YoY Change	654.33%	-2343.17%
Net Earnings / Revenue	-120.29%	-271.13%
Basic Earnings Per Share	-$0.54	-$1.46
Diluted Earnings Per Share	-$0.54	-$1.23
COMMON SHARES
Basic Shares Outstanding	600.1M	599.1M
Diluted Shares Outstanding	600.1M	600.3M

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$606.6M	$224.3M
YoY Change	87.18%	-25.79%
Cash & Equivalents	$606.6M	$224.3M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$1.271B	$901.9M
YoY Change	15.15%	-18.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.11B	$15.62B
YoY Change	-29.22%	-10.78%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.778B	$2.245B
YoY Change
Other Assets	$4.615M	$5.878M
YoY Change
Total Long-Term Assets	$14.92B	$16.54B
YoY Change	-17.55%	-10.78%
TOTAL ASSETS
Total Short-Term Assets	$1.271B	$901.9M
Total Long-Term Assets	$14.92B	$16.54B
Total Assets	$16.19B	$17.44B
YoY Change	-15.67%	-11.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$446.9M	$302.5M
YoY Change	0.44%	-49.18%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$606.9M	$465.8M
YoY Change	0.76%	-37.0%
LONG-TERM LIABILITIES
Long-Term Debt	$9.369B	$10.10B
YoY Change	-8.48%	-3.25%
Other Long-Term Liabilities	$25.70M	$32.08M
YoY Change	-48.36%	9.14%
Total Long-Term Liabilities	$9.395B	$10.13B
YoY Change	-8.68%	-3.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$606.9M	$465.8M
Total Long-Term Liabilities	$9.395B	$10.13B
Total Liabilities	$10.00B	$10.60B
YoY Change	-8.16%	-5.43%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.348B	-$1.847B
YoY Change	873.13%	7167.39%
Common Stock	$8.572B	$8.568B
YoY Change	0.28%	0.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.190B	$6.842B
YoY Change
Total Liabilities & Shareholders Equity	$16.19B	$17.44B
YoY Change	-15.67%	-11.24%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$320.6M	-$735.6M
YoY Change	654.33%	-2343.17%
Depreciation, Depletion And Amortization	$103.9M	$75.59M
YoY Change	-71.5%	-13.7%
Cash From Operating Activities	$35.26M	$74.34M
YoY Change	-53.93%	-45.19%
INVESTING ACTIVITIES
Capital Expenditures	$120.8M	$29.89M
YoY Change	-31.99%	-65.33%
Acquisitions
YoY Change
Other Investing Activities	$1.323B	-$89.38M
YoY Change	132.31%	-186.46%
Cash From Investing Activities	$1.202B	-$119.3M
YoY Change	206.8%	-794.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-853.5M	22.08M
YoY Change	84.82%	-124.77%
NET CHANGE
Cash From Operating Activities	35.26M	74.34M
Cash From Investing Activities	1.202B	-119.3M
Cash From Financing Activities	-853.5M	22.08M
Net Change In Cash	383.9M	-22.85M
YoY Change	5774.76%	-135.86%
FREE CASH FLOW
Cash From Operating Activities	$35.26M	$74.34M
Capital Expenditures	$120.8M	$29.89M
Free Cash Flow	-$85.56M	$44.46M
YoY Change	-15.38%	-10.11%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001287865
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q4	us-gaap	Real Estate Heldforsale RealEstateHeldforsale
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents Asset Statement Of Financial Position Extensible List RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssets
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Asset Statement Of Financial Position Extensible List RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssets
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents Asset Statement Of Financial Position Extensible List RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssets
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents Asset Statement Of Financial Position Extensible List RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssets
CY2023Q1	us-gaap	Derivative Instrument Gain Loss Reclassified From Aoci Into Income Effective Portion Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-32559
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	MEDICAL PROPERTIES TRUST, INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-0191742
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1000 URBAN CENTER DRIVE
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	SUITE 501
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	BIRMINGHAM
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	AL
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	35242
CY2024Q1	dei	City Area Code CityAreaCode	205
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	969-3755
CY2024Q1	dei	Security12b Title Security12bTitle	Common stock, par value $0.001 per share, of Medical Properties Trust, Inc.
CY2024Q1	dei	Trading Symbol TradingSymbol	MPW
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	600100000
CY2024Q1	mpw	Land Buildings And Improvements Intangible Lease Assets And Other LandBuildingsAndImprovementsIntangibleLeaseAssetsAndOther	12823748000
CY2023Q4	mpw	Land Buildings And Improvements Intangible Lease Assets And Other LandBuildingsAndImprovementsIntangibleLeaseAssetsAndOther	13237187000
CY2024Q1	us-gaap	Net Investment In Lease NetInvestmentInLease	1233178000
CY2023Q4	us-gaap	Net Investment In Lease NetInvestmentInLease	1231630000
CY2024Q1	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	295130000
CY2024Q1	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	309926000
CY2023Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	309315000
CY2024Q1	mpw	Gross Investment In Real Estate Assets GrossInvestmentInRealEstateAssets	14661982000
CY2023Q4	mpw	Gross Investment In Real Estate Assets GrossInvestmentInRealEstateAssets	14778132000
CY2024Q1	mpw	Real Estate Accumulated Depreciation And Amortization RealEstateAccumulatedDepreciationAndAmortization	1422728000
CY2023Q4	mpw	Real Estate Accumulated Depreciation And Amortization RealEstateAccumulatedDepreciationAndAmortization	1407971000
CY2024Q1	mpw	Net Investment In Real Estate Assets NetInvestmentInRealEstateAssets	13239254000
CY2023Q4	mpw	Net Investment In Real Estate Assets NetInvestmentInRealEstateAssets	13370161000
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	224340000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	250016000
CY2024Q1	mpw	Interest And Rent Receivable InterestAndRentReceivable	34492000
CY2023Q4	mpw	Interest And Rent Receivable InterestAndRentReceivable	45059000
CY2024Q1	mpw	Straight Line Rent Receivable StraightLineRentReceivable	677570000
CY2023Q4	mpw	Straight Line Rent Receivable StraightLineRentReceivable	635987000
CY2024Q1	us-gaap	Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures	1450482000
CY2023Q4	us-gaap	Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures	1474455000
CY2024Q1	mpw	Investments In Unconsolidated Operating Entities InvestmentsInUnconsolidatedOperatingEntities	794138000
CY2023Q4	mpw	Investments In Unconsolidated Operating Entities InvestmentsInUnconsolidatedOperatingEntities	1778640000
CY2024Q1	mpw	Acquisition Loans And Other Loans AcquisitionLoansAndOtherLoans	426971000
CY2023Q4	mpw	Acquisition Loans And Other Loans AcquisitionLoansAndOtherLoans	292615000
CY2024Q1	us-gaap	Other Assets OtherAssets	453709000
CY2023Q4	us-gaap	Other Assets OtherAssets	457911000
CY2024Q1	us-gaap	Assets Assets	17300956000
CY2023Q4	us-gaap	Assets Assets	18304844000
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	10098723000
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	10064236000
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	302526000
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	412178000
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	32076000
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	37962000
CY2024Q1	mpw	Obligations To Tenants And Other Lease Liabilities ObligationsToTenantsAndOtherLeaseLiabilities	163264000
CY2023Q4	mpw	Obligations To Tenants And Other Lease Liabilities ObligationsToTenantsAndOtherLeaseLiabilities	156603000
CY2024Q1	us-gaap	Liabilities Liabilities	10596589000
CY2023Q4	us-gaap	Liabilities Liabilities	10670979000
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	600304000
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	600304000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	598991000
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	598991000
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	600000
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	599000
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	8567199000
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	8560309000
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1846862000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-971809000
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-18838000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	42501000
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	6702099000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	7631600000
CY2024Q1	us-gaap	Minority Interest MinorityInterest	2268000
CY2023Q4	us-gaap	Minority Interest MinorityInterest	2265000
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6704367000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7633865000
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17300956000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18304844000
CY2024Q1	mpw	Rent Billed RentBilled	199299000
CY2023Q1	mpw	Rent Billed RentBilled	248157000
CY2024Q1	mpw	Straight Line Rent Revenue Net Of Write Offs StraightLineRentRevenueNetOfWriteOffs	44736000
CY2023Q1	mpw	Straight Line Rent Revenue Net Of Write Offs StraightLineRentRevenueNetOfWriteOffs	56693000
CY2024Q1	us-gaap	Direct Financing Lease Revenue DirectFinancingLeaseRevenue	16393000
CY2023Q1	us-gaap	Direct Financing Lease Revenue DirectFinancingLeaseRevenue	13195000
CY2024Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	10888000
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	32166000
CY2024Q1	us-gaap	Revenues Revenues	271316000
CY2023Q1	us-gaap	Revenues Revenues	350211000
CY2024Q1	us-gaap	Interest Expense InterestExpense	108685000
CY2023Q1	us-gaap	Interest Expense InterestExpense	97654000
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	75586000
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	83860000
CY2024Q1	mpw	Costs Of Leased And Rented Property Or Equipment CostsOfLeasedAndRentedPropertyOrEquipment	4818000
CY2023Q1	mpw	Costs Of Leased And Rented Property Or Equipment CostsOfLeasedAndRentedPropertyOrEquipment	7110000
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	33348000
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	41724000
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	222437000
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	230348000
CY2024Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-1423000
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	62000
CY2024Q1	mpw	Real Estate And Other Impairment Charges RealEstateAndOtherImpairmentCharges	693088000
CY2023Q1	mpw	Real Estate And Other Impairment Charges RealEstateAndOtherImpairmentCharges	89538000
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	10549000
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	11352000
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-229345000
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5166000
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-913307000
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-83290000
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-864428000
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	36573000
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10949000
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3543000
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-875377000
CY2023Q1	us-gaap	Profit Loss ProfitLoss	33030000
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	248000
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	236000
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-875625000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	32794000
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.46
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.46
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	600304000
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	598302000
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	600304000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	598310000
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.29
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-875377000
CY2023Q1	us-gaap	Profit Loss ProfitLoss	33030000
CY2024Q1	mpw	Other Comprehensive Income Unrealized Gain Loss On Derivatives Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesNetOfTax	-2797000
CY2023Q1	mpw	Other Comprehensive Income Unrealized Gain Loss On Derivatives Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesNetOfTax	-15325000
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	28553000
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-58542000
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	28143000
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-936716000
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	17295000
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	248000
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	236000
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-936964000
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	17059000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7633865000
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-875377000
CY2024Q1	mpw	Other Comprehensive Income Unrealized Gain Loss On Derivatives Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesNetOfTax	-2797000
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-58542000
CY2024Q1	mpw	Stock Issued During Period Value Stock Vesting And Amortization Of Stock Based Compensation StockIssuedDuringPeriodValueStockVestingAndAmortizationOfStockBasedCompensation	7174000
CY2024Q1	mpw	Stock Issued During Period Value Stock Vesting Satisfaction Of Tax Withholding StockIssuedDuringPeriodValueStockVestingSatisfactionOfTaxWithholding	-283000
CY2024Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	245000
CY2024Q1	mpw	Dividends Declared Adjustment DividendsDeclaredAdjustment	572000
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6704367000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8594407000
CY2023Q1	us-gaap	Profit Loss ProfitLoss	33030000
CY2023Q1	mpw	Other Comprehensive Income Unrealized Gain Loss On Derivatives Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesNetOfTax	-15325000
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	28143000
CY2023Q1	mpw	Reclassification Of Interest Rate Swap Gain To Earnings Net Of Tax ReclassificationOfInterestRateSwapGainToEarningsNetOfTax	-28553000
CY2023Q1	mpw	Stock Issued During Period Value Stock Vesting And Amortization Of Stock Based Compensation StockIssuedDuringPeriodValueStockVestingAndAmortizationOfStockBasedCompensation	11829000
CY2023Q1	mpw	Stock Issued During Period Value Stock Vesting Satisfaction Of Tax Withholding StockIssuedDuringPeriodValueStockVestingSatisfactionOfTaxWithholding	-5554000
CY2023Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	231000
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.29
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	174492000
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8443254000
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-875377000
CY2023Q1	us-gaap	Profit Loss ProfitLoss	33030000
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	77214000
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	87586000
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3698000
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	4014000
CY2024Q1	mpw	Straight Line Rent Revenue And Other StraightLineRentRevenueAndOther	46566000
CY2023Q1	mpw	Straight Line Rent Revenue And Other StraightLineRentRevenueAndOther	58566000
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	7633000
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	11829000
CY2024Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-1423000
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	62000
CY2024Q1	mpw	Real Estate And Other Impairment Charges Recovery RealEstateAndOtherImpairmentChargesRecovery	693088000
CY2023Q1	mpw	Real Estate And Other Impairment Charges Recovery RealEstateAndOtherImpairmentChargesRecovery	89538000
CY2024Q1	mpw	Straight Line Rent And Other Write Off StraightLineRentAndOtherWriteOff	1817000
CY2023Q1	mpw	Straight Line Rent And Other Write Off StraightLineRentAndOtherWriteOff	2192000
CY2024Q1	mpw	Tax Rate Changes TaxRateChanges	-307000
CY2023Q1	mpw	Tax Rate Changes TaxRateChanges	-7305000
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-223674000
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	8505000
CY2024Q1	mpw	Increase Decrease In Interest And Rent Receivable IncreaseDecreaseInInterestAndRentReceivable	-5369000
CY2023Q1	mpw	Increase Decrease In Interest And Rent Receivable IncreaseDecreaseInInterestAndRentReceivable	514000
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-5689000
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2493000
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-18878000
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-15696000
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-4135000
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	600000
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	74342000
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	135648000
CY2023Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	72900000
CY2024Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	6596000
CY2023Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	100000
CY2024Q1	us-gaap	Proceeds From Sale Of Loans Receivable ProceedsFromSaleOfLoansReceivable	114416000
CY2023Q1	us-gaap	Proceeds From Sale Of Loans Receivable ProceedsFromSaleOfLoansReceivable	221876000
CY2024Q1	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	135000000
CY2023Q1	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	50000000
CY2024Q1	mpw	Construction In Progress Equipment And Other ConstructionInProgressEquipmentAndOther	29885000
CY2023Q1	mpw	Construction In Progress Equipment And Other ConstructionInProgressEquipmentAndOther	13292000
CY2024Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	11656000
CY2024Q1	mpw	Payments For Capital Additions And Other Investments Net PaymentsForCapitalAdditionsAndOtherInvestmentsNet	87045000
CY2023Q1	mpw	Payments For Capital Additions And Other Investments Net PaymentsForCapitalAdditionsAndOtherInvestmentsNet	68606000
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-119262000
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	17178000
CY2024Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	111186000
CY2023Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	95919000
CY2024Q1	us-gaap	Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends	92763000
CY2023Q1	us-gaap	Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends	176580000
CY2024Q1	mpw	Payments For Proceeds From Lease Deposits And Other Obligations To Tenants PaymentsForProceedsFromLeaseDepositsAndOtherObligationsToTenants	-6226000
CY2023Q1	mpw	Payments For Proceeds From Lease Deposits And Other Obligations To Tenants PaymentsForProceedsFromLeaseDepositsAndOtherObligationsToTenants	2691000
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	283000
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	5554000
CY2024Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-2291000
CY2023Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-219000
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	22075000
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-89125000
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-22845000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	63701000
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2889000
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2927000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	255952000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	241538000
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	230218000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	308166000
CY2024Q1	us-gaap	Interest Paid InterestPaid	131815000
CY2023Q1	us-gaap	Interest Paid InterestPaid	116436000
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	174492000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	250016000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	235668000
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	5936000
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	5870000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	255952000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	241538000
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	224340000
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	302321000
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	5878000
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	5845000
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	230218000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	308166000
CY2024Q1	mpw	Percentage Of Leased Assets Owned PercentageOfLeasedAssetsOwned	1
CY2024Q1	mpw	Number Of Facilities NumberOfFacilities	436
CY2024Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	31
CY2024Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Reclassifications</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain amounts in the condensed consolidated financial statements for prior periods have been reclassified to conform to the current period presentation.</span></p>
CY2024Q1	mpw	Minimum Percentage Of Reconciling Items Quantitative Threshold Of The Statutory Tax MinimumPercentageOfReconcilingItemsQuantitativeThresholdOfTheStatutoryTax	0.05
CY2024Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	0
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	72900000
CY2023Q1	mpw	Business Combination Loans Paid Down On Acquisition Loans BusinessCombinationLoansPaidDownOnAcquisitionLoans	22900000
CY2024Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	0
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	50000000
CY2024Q1	mpw	Development Projects Original Commitment Amount DevelopmentProjectsOriginalCommitmentAmount	89592000
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	40885000
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	79000000
CY2023Q1	mpw	Straight Line Rent Receivables StraightLineRentReceivables	37400000
CY2023Q1	mpw	Estimated Fees To Sell The Hospitals EstimatedFeesToSellTheHospitals	8000000
CY2023Q1	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	16000000
CY2024Q1	us-gaap	Lessor Operating Lease Renewal Term LessorOperatingLeaseRenewalTerm	P5Y
CY2024Q1	mpw	Leases Annual Rent Escalations Percentage LeasesAnnualRentEscalationsPercentage	0.99
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	456592000
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	121972000
CY2024Q1	us-gaap	Direct Financing Lease Lease Receivable DirectFinancingLeaseLeaseReceivable	606537000
CY2023Q4	us-gaap	Direct Financing Lease Lease Receivable DirectFinancingLeaseLeaseReceivable	611669000
CY2024Q1	us-gaap	Direct Financing Lease Unguaranteed Residual Asset DirectFinancingLeaseUnguaranteedResidualAsset	203818000
CY2023Q4	us-gaap	Direct Financing Lease Unguaranteed Residual Asset DirectFinancingLeaseUnguaranteedResidualAsset	203818000
CY2024Q1	mpw	Direct Financing Lease Unearned Income And Allowance For Credit Loss DirectFinancingLeaseUnearnedIncomeAndAllowanceForCreditLoss	565116000
CY2023Q4	mpw	Direct Financing Lease Unearned Income And Allowance For Credit Loss DirectFinancingLeaseUnearnedIncomeAndAllowanceForCreditLoss	571059000
CY2024Q1	us-gaap	Direct Financing Lease Net Investment In Lease DirectFinancingLeaseNetInvestmentInLease	245239000
CY2023Q4	us-gaap	Direct Financing Lease Net Investment In Lease DirectFinancingLeaseNetInvestmentInLease	244428000
CY2024Q1	mpw	Other Financing Leases Net Of Allowance For Credit Loss OtherFinancingLeasesNetOfAllowanceForCreditLoss	987939000
CY2023Q4	mpw	Other Financing Leases Net Of Allowance For Credit Loss OtherFinancingLeasesNetOfAllowanceForCreditLoss	987202000
CY2024Q1	us-gaap	Net Investment In Lease NetInvestmentInLease	1233178000
CY2023Q4	us-gaap	Net Investment In Lease NetInvestmentInLease	1231630000
CY2024Q1	mpw	Percentage Of Vacant On Leased Property PercentageOfVacantOnLeasedProperty	0.003
CY2024Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	220000000
CY2024Q1	us-gaap	Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures	1450482000
CY2023Q4	us-gaap	Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures	1474455000
CY2024Q1	mpw	Investments In Unconsolidated Operating Entities InvestmentsInUnconsolidatedOperatingEntities	794138000
CY2023Q4	mpw	Investments In Unconsolidated Operating Entities InvestmentsInUnconsolidatedOperatingEntities	1778640000
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	96001000
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	121146000
CY2024Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	362187000
CY2023Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	986000
CY2024Q1	mpw	Financing Receivable Allowances Of Credit Losses Related To Financial Instruments Sold FinancingReceivableAllowancesOfCreditLossesRelatedToFinancialInstrumentsSold	-1596000
CY2023Q1	mpw	Financing Receivable Allowances Of Credit Losses Related To Financial Instruments Sold FinancingReceivableAllowancesOfCreditLossesRelatedToFinancialInstrumentsSold	-160000
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	10146575000
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	10109133000
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	47852000
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	44897000
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	10098723000
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	10064236000
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	438839000
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1423110000
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	3285441000
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1600000000
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	757380000
CY2024Q1	mpw	Long Term Debt Maturities Repayments Of Principal After Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour	2641805000
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	10146575000
CY2024Q1	mpw	Percentage Of Dividends Payable On Basis Of Adjusted Operating Funds PercentageOfDividendsPayableOnBasisOfAdjustedOperatingFunds	0.95
CY2024Q1	mpw	Percentage Of Dividends Payable On Senior Unsecured Notes PercentageOfDividendsPayableOnSeniorUnsecuredNotes	0.95
CY2024Q1	mpw	Maximum Percentage Of Unencumbered Assets MaximumPercentageOfUnencumberedAssets	1.50
CY2024Q1	mpw	Income Tax Benefit Related To The Initial Loan Impairment IncomeTaxBenefitRelatedToTheInitialLoanImpairment	5000000
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	7600000
CY2024Q1	mpw	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant With Cash Settlement ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantWithCashSettlement	500000
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	11800000
CY2024Q1	mpw	Interest And Rent Receivable InterestAndRentReceivable	34492000
CY2024Q1	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	34730000
CY2023Q4	mpw	Interest And Rent Receivable InterestAndRentReceivable	45059000
CY2023Q4	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	45476000
CY2024Q1	mpw	Loans Loans	955388000
CY2024Q1	us-gaap	Loans Held For Sale Fair Value Disclosure LoansHeldForSaleFairValueDisclosure	900597000
CY2023Q4	mpw	Loans Loans	1302727000
CY2023Q4	us-gaap	Loans Held For Sale Fair Value Disclosure LoansHeldForSaleFairValueDisclosure	1202383000
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	10098723000
CY2024Q1	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	8619882000
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	10064236000
CY2023Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	8256465000
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-875377000
CY2023Q1	us-gaap	Profit Loss ProfitLoss	33030000
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	248000
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	236000
CY2024Q1	mpw	Undistributed Earning Allocated To Participating Securities UndistributedEarningAllocatedToParticipatingSecurities	0
CY2023Q1	mpw	Undistributed Earning Allocated To Participating Securities UndistributedEarningAllocatedToParticipatingSecurities	515000
CY2024Q1	mpw	Net Income Less Participating Securities Share In Earnings NetIncomeLessParticipatingSecuritiesShareInEarnings	-875625000
CY2023Q1	mpw	Net Income Less Participating Securities Share In Earnings NetIncomeLessParticipatingSecuritiesShareInEarnings	32279000
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	600304000
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	598302000
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	8000
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	600304000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	598310000
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	mpw	Rule10 B51 Arr Mofified Flag Rule10B51ArrMofifiedFlag	false
CY2024Q1	mpw	Non Rule10 B51 Arr Modified Flag NonRule10B51ArrModifiedFlag	false

Files In Submission

Name	View Source	Status
0000950170-24-065929-index-headers.html	Edgar Link	pending
0000950170-24-065929-index.html	Edgar Link	pending
0000950170-24-065929.txt	Edgar Link	pending
0000950170-24-065929-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mpw-20240331.htm	Edgar Link	pending
mpw-20240331.xsd	Edgar Link	pending
mpw-ex10_1.htm	Edgar Link	pending
mpw-ex10_2.htm	Edgar Link	pending
mpw-ex31_1.htm	Edgar Link	pending
mpw-ex31_2.htm	Edgar Link	pending
mpw-ex31_3.htm	Edgar Link	pending
mpw-ex31_4.htm	Edgar Link	pending
mpw-ex32_1.htm	Edgar Link	pending
mpw-ex32_2.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mpw-20240331_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MPW
MEDICAL PROPERTIES TRUST INC Stock $mpw

2024 Q2 Form 10-Q Financial Statement

#000095017024065929 Filed on May 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MPW MEDICAL PROPERTIES TRUST INC Stock $mpw

2024 Q2 Form 10-Q Financial Statement

#000095017024065929 Filed on May 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MPW
MEDICAL PROPERTIES TRUST INC Stock $mpw